Covered recipient · General Payments record
SRIREKHA MADDUKURI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$18,541.58
- Reported across 1,284 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,987.69 | 100 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $689.78 | 38 |
| Biogen, Inc. | $141.70 | 7 |
| PFIZER INC. | $116.86 | 6 |
| HARMONY BIOSCIENCES LLC | $97.30 | 6 |
| Lilly USA, LLC | $81.44 | 4 |
| EMD Serono, Inc. | $79.96 | 4 |
| Amgen Inc. | $75.46 | 4 |
| Alexion Pharmaceuticals, Inc. | $70.09 | 3 |
| Merz Pharmaceuticals, LLC | $66.53 | 2 |
| Grifols USA, LLC | $56.64 | 2 |
| Octapharma USA, Inc. | $53.70 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $50.23 | 3 |
| GE HEALTHCARE | $40.75 | 2 |
| EISAI INC. | $39.64 | 2 |
| ARGENX US, INC. | $39.51 | 2 |
| Teva Pharmaceuticals USA, Inc. | $36.69 | 1 |
| JAZZ PHARMACEUTICALS INC. | $32.85 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $27.29 | 2 |
| UCB, Inc. | $25.92 | 1 |
| Amneal Pharmaceuticals LLC | $25.90 | 1 |
| Alnylam Pharmaceuticals Inc. | $25.67 | 1 |
| Axsome Therapeutics, Inc. | $23.94 | 1 |
| TG THERAPEUTICS, INC. | $22.27 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $22.15 | 1 |
| LivaNova USA, Inc. | $15.89 | 1 |
| Celgene Corporation | $15.45 | 1 |
| ACADIA Pharmaceuticals Inc | $14.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (100)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.